USPTO trademark

NOVOCURE

AllowedUSPTOWord markClass 9Class 35Class 42

"NOVOCURE" is a word mark owned by Novocure GmbH, filed at the USPTO on May 19, 2025. It has been allowed and covers classes 9, 35 and 42.

View Novocure GmbH portfolioGet this data via the API
Official USPTO record
NOVOCURE trademark as filed
As filed with the USPTO
Status
Allowed
Since August 12, 2026
Filed
May 19, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99191347
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns NOVOCURE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Novocure GmbH

NVCR · Baar, Switzerland

27 trademarks in the portfolioView company

Representative

Hara K Jacobs

Ballard Spahr LLP

Goods and services

What the mark covers

The products and services NOVOCURE is filed for, grouped by Nice class.

  • Downloadable software for capturing, storing, tracking, monitoring, analysing and transmitting medical information and data; downloadable mobile application software for capturing, storing, tracking, monitoring, analysing and transmitting medical information and data; downloadable mobile application software for use in the treatment, evaluation, monitoring and staging of cancer; downloadable software for mobile phones for capturing, storing, tracking, monitoring, analysing and transmitting medical information and data; downloadable software and downloadable mobile application software for use in the treatment, evaluation, monitoring and staging of cancer; downloadable software and downloadable mobile application software for capturing, storing, tracking, monitoring, analysing and transmitting medical data; downloadable software and downloadable mobile application software for conducting clinical trials; electronic communication transmission and receiving equipment and instruments for use in the treatment, evaluation, monitoring and staging of cancer; electronic communication transmission and receiving devices for use in the treatment, evaluation, monitoring and staging of cancer; electronic communication transmission and receiving devices for collecting medical data from a medical device that treats cancer and transmitting medical data to the provider of the medical device

  • Compilation of medical reports, not for research purposes; processing and compilation of medical data, not for research purposes; maintaining patient medical history records and files; providing business information about the administration of patient reimbursement programs designed to assist patients requiring treatment of cancer; business administration of patient reimbursement programs for patients requiring treatment of cancer; information, advisory and consultancy services related to the aforesaid

  • Software as a service (SaaS) featuring software for capturing, storing, tracking, monitoring, analysing and transmitting medical information and data; providing temporary use of online non-downloadable software for capturing, storing, tracking, monitoring, analysing and transmitting medical information and data; providing temporary use of online non-downloadable software for use in the treatment, evaluation, monitoring and staging of cancer; providing temporary use of online non-downloadable software and mobile applications for capturing, storing, tracking, monitoring, analysing and transmitting medical data; providing temporary use of online non-downloadable software and mobile applications for conducting clinical trials; medical research services; calibration of medical apparatus and devices; analysis of statistical data for scientific research; Scientific research in the nature of conducting clinical trials for others; information, advisory and consultancy services related to the aforesaid

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 1 granted
  3. Sou extension 1 filed
  4. Sou teas extension received
  5. Noa e-mailed - sou required from applicant
  6. Official gazette publication confirmation e-mailed
  7. Published for opposition
  8. Notification of notice of publication e-mailed
  9. Approved for pub - principal register
  10. Examiner's amendment entered

10 earlier steps on the official record.

FAQ

About NOVOCURE

Who owns the trademark "NOVOCURE"?

The USPTO trademark "NOVOCURE" (application 99191347) is owned by Novocure GmbH.

What is the status of "NOVOCURE"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NOVOCURE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2ac9-d842-7572-adff-dbb73f9ff5b8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ac9-d842-7572-adff-dbb73f9ff5b8",
  "object": "trademark",
  "mark_text": "NOVOCURE",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99191347",
  "filing_date": "2025-05-19",
  "nice_classes": [
    9,
    35,
    42
  ],
  "owners": [
    {
      "name": "Novocure GmbH",
      "entity_id": "ent_019f2860-d10e-72fd-9e29-64d4f9702921"
    }
  ]
}